Results 161 to 170 of about 408,319 (335)

Epigenetics of Dendritic Cells in Tumor Immunology. [PDF]

open access: yesCancers (Basel), 2022
Godoy-Tena G, Ballestar E.
europepmc   +1 more source

Cholesterol in mRNA‐Lipid Nanoparticles can be Replaced with the Synthetic Mycobacterial Monomycoloyl Glycerol Analogue MMG‐1

open access: yesAdvanced Functional Materials, EarlyView.
This study demonstrates that cholesterol in messenger RNA‐lipid nanoparticles (mRNA‐LNPs) can be completely replaced with an immunopotentiating lipid, i.e., a synthetic analogue of the C‐type lectin receptor agonist monomycoloyl glycerol (MMG‐1), without compromising physicochemical properties, in vivo transfection efficiency, and immunogenicity of the
Abhijeet G. Lokras   +19 more
wiley   +1 more source

Lung cancer in never smokers: Tumor immunology and challenges for immunotherapy. [PDF]

open access: yesFront Immunol, 2022
de Alencar VTL   +4 more
europepmc   +1 more source

Synergism of PDL/PD1 and IL33/ST2 Axis in Tumor Immunology [PDF]

open access: hybrid, 2019
Marina Jovanović   +4 more
openalex   +1 more source

Biomaterial Strategies for Targeted Intracellular Delivery to Phagocytes

open access: yesAdvanced Functional Materials, EarlyView.
Phagocytes are essential to a functional immune system, and their behavior defines disease outcomes. Engineered particles offer a strategic opportunity to target phagocytes, harnessing inflammatory modulation in disease. By tuning features like size, shape, and surface, these systems can modulate immune responses and improve targeted treatment for a ...
Kaitlyn E. Woodworth   +2 more
wiley   +1 more source

Tumor immunology CRISPR screening: present, past, and future. [PDF]

open access: yesTrends Cancer, 2022
Dong MB   +4 more
europepmc   +1 more source

Outlook Magazine, Winter 2018 [PDF]

open access: yes, 2018
https://digitalcommons.wustl.edu/outlook/1206/thumbnail ...

core   +1 more source

Home - About - Disclaimer - Privacy